CONSOLACIÓN MELGUIZO ALONSO-rekin lankidetzan egindako argitalpenak (8)

2020

  1. Gemcitabine-loaded magnetically responsive poly(ε-caprolactone) nanoparticles against breast cancer

    Polymers, Vol. 12, Núm. 12, pp. 1-17

2019

  1. Oxaliplatin–biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: An in vitro study

    Pharmaceutics, Vol. 11, Núm. 8

2018

  1. Formulation and in vitro evaluation of magnetoliposomes as a potential nanotool in colorectal cancer therapy

    Colloids and Surfaces B: Biointerfaces, Vol. 171, pp. 553-565

  2. Nano-engineering of biomedical prednisolone liposomes: evaluation of the cytotoxic effect on human colon carcinoma cell lines

    Journal of Pharmacy and Pharmacology, Vol. 70, Núm. 4, pp. 488-497

2017

  1. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs

    AAPS PharmSciTech, Vol. 18, Núm. 8, pp. 3042-3052

  2. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil

    International Journal of Pharmaceutics, Vol. 516, Núm. 1-2, pp. 61-70

  3. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study

    European Journal of Pharmaceutical Sciences, Vol. 102, pp. 24-34

2015

  1. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles

    Drug Design, Development and Therapy, Vol. 9, pp. 6433-6444